Home LiteratureArticle Details
PMID: 21288925 Published · ppublish English Comment Journal Article

A new mechanism for blocking myeloid-derived suppressor cells by CpG.

Lechner MG, Epstein AL

Abstract

In this issue of Clinical Cancer Research, Zoglmeier and colleagues show that CpG, via the induction of IFN-α, matures myeloid-derived suppressor cells to abrogate immune suppression in 2 murine solid tumor models.

MeSH Terms
Animals Antineoplastic Agents/pharmacology,therapeutic use DNA/pharmacology,therapeutic use Humans Immune Tolerance Immunotherapy Myeloid Cells/drug effects,immunology Neoplasms/immunology,therapy Oligodeoxyribonucleotides Toll-Like Receptor 9/agonists
Chemicals
Antineoplastic Agents CpG ODN 1826 Oligodeoxyribonucleotides Toll-Like Receptor 9 DNA
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lechner Melissa G
Systems Biology and Disease Graduate Program, University of Southern California, Los Angeles, California, USA.
Epstein Alan L
References (18)
18 references, click to expand
  1. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.
    Clin Cancer Res. 2010 Sep 15;16(18):4583-94 PMID: 20702612
  2. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.
    J Clin Invest. 2010 Feb;120(2):457-71 PMID: 20093776
  3. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9305-10 PMID: 10430938
  4. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
    J Immunol. 2010 Aug 15;185(4):2273-84 PMID: 20644162
  5. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.
    Int Immunopharmacol. 2009 Jul;9(7-8):900-9 PMID: 19336265
  6. CpG motifs: the active ingredient in bacterial extracts?
    Nat Med. 2003 Jul;9(7):831-5 PMID: 12835699
  7. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
    Clin Cancer Res. 2009 Mar 15;15(6):2148-57 PMID: 19276286
  8. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.
    BMC Cancer. 2010 Aug 30;10:464 PMID: 20804550
  9. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
    Clin Cancer Res. 2011 Apr 1;17(7):1765-75 PMID: 21233400
  10. Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.
    Clin Cancer Res. 2007 Jul 1;13(13):4016-25 PMID: 17606736
  11. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
    Blood. 2010 Feb 18;115(7):1461-71 PMID: 20008303
  12. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.
    Trends Immunol. 2011 Jan;32(1):19-25 PMID: 21067974
  13. A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression.
    Blood. 2008 Feb 1;111(3):1437-47 PMID: 17991807
  14. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.
    J Exp Med. 2006 Nov 27;203(12):2691-702 PMID: 17101732
  15. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.
    Cancer Res. 2010 Apr 15;70(8):3052-61 PMID: 20388795
  16. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells.
    Cancer Res. 2007 Nov 15;67(22):11021-8 PMID: 18006848
  17. Toll-like receptors in tumor immunotherapy.
    Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5280-9 PMID: 17875756
  18. Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination.
    Int J Cancer. 2011 Nov 1;129(9):2158-70 PMID: 21170961
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1557-3265
Published
2011-04-01
Epub
2011-00-02
Pages
1645-8
Language
English
Region
United States
NLM ID
9502500
PMCID
PMC4237605
Subset
IM
Grants
NCI NIH HHS · P30 CA014089 · United States
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com